Sichuan Hebang Biotechnology Co Ltd

As of 5 p.m. on August 20, 498 companies listed on the Shenzhen Stock Exchange had released their 2026 half-year reports. Among them, 313 companies posted year-on-year profit growth in the first half, accounting for more than 60 percent. A total of 157 companies saw growth of more than 50 percent, and 112 companies more than doubled their earnings. The sectors with high growth were mainly concentrated in five areas: basic chemicals, power equipment, electronics, machinery equipment, and nonferrous metals. In basic chemicals, Do-Fluoride New Materials reported net profit attributable to shareholders of 512 million yuan in the first half, up 897.19 percent year on year. Huachang Chemical posted net profit of 123 million yuan, up 1,026.90 percent. Hebang Biotechnology reported net profit of 380 million yuan, up 634.30 percent. In power equipment, CATL posted net profit attributable to shareholders of 43.28 billion yuan in the first half, up 42.0 percent year on year. In electronics, Yunhan Xin Cheng achieved operating revenue of 2.746 billion yuan, up 90.66 percent, with net profit attributable to shareholders of 166 million yuan. In nonferrous metals, Tin Industry Company achieved operating revenue of 31.573 billion yuan, up 49.68 percent, and net profit attributable to shareholders of 1.504 billion yuan, up 41.60 percent. In machinery equipment, Ding Tai High-Tech achieved operating revenue of 1.943 billion yuan, up 114.85 percent, and net profit attributable to shareholders of 679 million yuan, up 325.12 percent. Industry insiders noted that the overall performance of Shenzhen-listed companies that have disclosed half-year reports is improving, and the five major sectors have become concentrated areas of high profit growth, reflecting a positive trend of recovery in the real economy's industrial cycle and continuously strengthening momentum in emerging industries.

Hebang Biotech released its 2026 interim report, with net profit attributable to the parent company of 380 million yuan, up 634.30% from the same period last year. Total operating revenue was 2.888 billion yuan, a decrease of 1.033 billion yuan from the same reporting period last year, down 26.34% year-on-year. Net cash inflow from operating activities was 189 million yuan, up 29.98% year-on-year, achieving two consecutive years of growth. The company's latest asset-liability ratio was 34.74%, down 1.96 percentage points from the previous quarter; the latest gross margin was 28.87%, up 4.50 percentage points from the previous quarter, achieving four consecutive quarters of growth.

On the evening of the 17th, multiple A-share companies disclosed their 2026 half-year reports, with first-half net profits rising sharply year on year. Sunwave Communications achieved net profit attributable to owners of the parent company of 50.3935 million yuan, up 1,825.74 percent year on year; Youngy Company posted net profit of 1.002 billion yuan, up 1,076.14 percent; Do-Fluoride New Materials reported net profit of 512 million yuan, up 897.19 percent. In addition, companies including Grand Industrial Holding, Hebang Biotechnology, Chengxing Group, Shanghai Ailu Package, Zhaojin Gold, Fudan Microelectronics, Raytron Technology, and Decole saw year-on-year net profit growth of more than 100 percent, among which 10 stocks including Shenzhen Keda achieved net profit growth of over 100 percent year on year. CSPC Innovation Pharmaceutical, Tianhua New Energy, Minmetals New Energy, and Zhangjiajie Tourism turned losses into profits year on year.

Chemical Industry ETF Penghua rose 0.53% to 0.76 yuan. Institutions note that the chemical sector now offers high investment payoff, with key market concerns partly disproven, including a sharp rise in oil prices, US interest rate hikes curbing consumption, and weaker-than-expected domestic demand. Industry inventories are at a bottom range, per-tonne profits for most products have fallen to historical lows, and the medium- to long-term supply-demand outlook is improving. The CSI Subdivision Chemical Industry Thematic Index rose 0.25%, with constituents Hengyi Petrochemical up 6.28% and Hebang Biotech up 5.29%. Chemical Industry ETF Penghua closely tracks this index, with its top ten holdings accounting for 43.96% of the total.

Hebang Biotech disclosed an earnings forecast, expecting net profit attributable to shareholders of the listed company for the first half of 2026 to be between 370 million and 430 million yuan, an increase of 614.68% to 730.57% year-on-year. In the first half, affected by geopolitical conflicts, the methionine industry saw overall production capacity decline due to raw material shortages, widening the supply gap and raising the cost base, which drove a rapid increase in methionine prices and boosted segment profits. Also affected by geopolitical conflicts, the cost of raw materials such as yellow phosphorus rose rapidly, and the United States included elemental phosphorus and key herbicides like glyphosate in its list of critical strategic materials, pushing up prices of glyphosate and diglyphosate and significantly improving segment profits.